Sutro Biopharma (S090.F) Q2 2026 Earnings

May 14Confirmed
Q4 2025
Q2 2026
-5.8
-4.65
-3.5
-2.35

Details

Expected EPS
-2.3458317045999997
Actual EPS
-2.5204619999999998
Surprise EPS
-0.17
Surprise Percent
-7.44%

Description

⁨Sutro Biopharma⁩ (⁦S090.F⁩) has reported earnings of ⁦-2.5204619999999998⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts